27-Mar-2024
No headlines found.
Teleflex's Climate Targets Validated by the Science Based Targets Initiative
Globe Newswire (Thu, 28-Mar 6:30 AM ET)
Glancy Prongay & Murray LLP Announces Investigation of Teleflex Incorporated (TFX)
Business Wire (Thu, 14-Mar 4:09 PM ET)
Teleflex Announces Quarterly Dividend
Globe Newswire (Thu, 22-Feb 6:45 AM ET)
Teleflex Reports Fourth Quarter and Full Year 2023 Financial Results
Globe Newswire (Thu, 22-Feb 6:30 AM ET)
Teleflex to Present at the 45th Annual Raymond James Institutional Investors Conference
Globe Newswire (Tue, 20-Feb 6:30 AM ET)
Teleflex Announces Fourth Quarter 2023 Earnings Conference Call Information
Globe Newswire (Thu, 8-Feb 6:30 AM ET)
Teleflex now offers its Titan SGS Stapler with Staple Line Reinforcement
Globe Newswire (Tue, 9-Jan 6:30 AM ET)
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2023 sales), interventional (17%), anesthesia (13%), surgical (14%), interventional urology (11%), original-equipment manufacturing (11%), and other (10%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
Teleflex trades on the NYSE stock market under the symbol TFX.
As of March 27, 2024, TFX stock price climbed to $223.87 with 290,530 million shares trading.
TFX has a beta of 1.79, meaning it tends to be more sensitive to market movements. TFX has a correlation of 0.42 to the broad based SPY ETF.
TFX has a market cap of $10.53 billion. This is considered a Large Cap stock.
Last quarter Teleflex reported $774 million in Revenue and $3.38 earnings per share. This beat revenue expectation by $5 million and exceeded earnings estimates by $.12.
In the last 3 years, TFX stock traded as high as $449.38 and as low as $177.63.
The top ETF exchange traded funds that TFX belongs to (by Net Assets): VTI, VOO, VB, SPY, VO.
TFX has underperformed the market in the last year with a price return of -8.8% while the SPY ETF gained +33.6%. TFX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -10.5% and +0.8%, respectively, while the SPY returned +10.1% and +1.7%, respectively.
TFX support price is $212.97 and resistance is $219.81 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TFX stock will trade within this expected range on the day.